Many laboratories have been raising monoclonal antibodies to cell-surface antigens of human epithelia and epithelial tumours in the hope of applying them to the diagnosis, detection and therapy of malignancy (reviews: monoclonal antibodies in general, Edwards, 1981; used in pathology, Neville et al., 1982; Damjanov & Knowles, 1983 ; in therapy, Levy & Miller, 1983;  antigens on tumour cells, Lloyd, 1983) . Perhaps the most interesting observation that has come out of this work is that when a tumour or normal epithelium is stained with a given antibody only some of the cells in the tumour or epithelium bind the antibody. In other words, the antibodies appear to define distinct populations of cells in normal and neoplastic epithelia. This clearly poses problems for therapy and diagnosis, as a given antibody will only bind detectably to a proportion of cells in a given tumour. In this review I have attempted to summarise what we know and do not know about this phenomenon and its biological significance, and to discuss its implications not only for the development of antibody therapy and diagnosis, but also for the study of the cellular heterogeneity of tumours.
The illustrations are taken from work of this laboratory purely for convenience and the advantages of colour. As far as I am aware the general phenomena of staining that are illustrated are similar to those obtained with the antibodies raised in other laboratories. (Arklie et al., 1981; Colcher et al., 1981; Ellis et al., 1984; Foster et al., 1982a, b; Hilkens et al., 1984) . Of other anti-breast antibodies that have been tested on sections of tumour, it is not stated whether staining is 2 Legend to Colour Plate Examples of heterogeneous antigen expression by tumours, normal epitheliuin and cloned cells in culture.
For convenience these examples were obtained using the author's monoclonal antibodies, but they are representative of the antibodies in the field.
Figures 1 and 2 Typical staining of tumour sections by monoclonal antibodies. Some cells are positive, others, apparently of the same morphology, are negative. In (1) the distribution of positive cells is scattered, in (2) whole areas of tumour are positive or negative. Conventional paraffin sections were stained by the immunoperoxidase method which produces a brown reaction product where antibody has bound. Blue is a haemalum counterstain to show nuclei. Monoclonal antibody LICR-LON-M8 (Foster et al., 1982b) Figures 3 to 5 Antigenic heterogeneity in normal epithelia, demonstrated by two-colour immunofluorescence (Edwards & Brooks, 1984 and unpublished) . (3) Normal endometrium, which displays an apparently random pattern of antigens. The tissue was stained intact and unfixed, as a sheet, and is viewed en face, not in section. Each patch of colour is the apical membrane of an individual cell. Monoclonal antibodies LICR-LON-M8 (green fluorescence) and LICR-LON-M24 (red fluorescence). Yellow cells are those stained by both antibodies, x 300. (4) Normal breast duct epithelium, which shows reproducible, recognisable patterns of antigen expression. Stained as a sheet of tissue obtained by dissecting out a duct and splitting it along its length (Edwards & Brooks, 1984) . Viewed en face, not in section, as in (3), x 300. Antibodies and colours as in (3). (5) Frozen section of normal human colon, where antigen expression seems to be linked to the maturation of the cells. Staining by antibody LICR-LON-M8 (in green) seems concentrated in the crypts, and as the cells pass up the crypts they increasingly express antigen LICR-LON-M24 (red). Antibodies and colours as in (3) and (4), x 70. Figure 6 Antigenic heterogeneity in a single-cell clone of normal breast epithelial cells, showing that heterogeneity is rapidly regenerated in clones. Normal breast epithelium cells were obtained by digestion with collagenase (Easty et al., 1980) then trypsin + EDTA. Single cells were isolated by micromanipulation to ensure single-cell origin of the clones (Zagury et al., 1981) , and grown on a sparse feeder layer in petri dishes (Stoker et al., 1982) . Monoclonal antibodies LICR-LON-M8 (green) and LICR-LON-M24 (red), x 200. heterogeneous, e.g. MBrl and MOvI (Menard et al., 1983) , but experience with these antibodies, many of which have now been exchanged between laboratories, shows that it usually will be. Colon (Arends et al., 1983; Daar & Fabre, 1982; Finan et al., 1982) and lung (Wagenaar et al., 1984) tumours also show heterogeneity. In melanoma antibodies shown to stain heterogeneously include Me4-TB7, C13-C6 and Nu4B (Carrel et al., 1982; Thompson et al., 1982) as well as antibodies to HLA-DR as discussed below. The antibody SSEA-1 shows heterogenous staining of colon, stomach and kidney carcinoma, although breast carcinoma was almost homogeneously positive (Fox et al., 1983) . The antibody Cal (McGee et al., 1982) stains various tumours heterogeneously. These are only examples -many more have been reported. The antigens are in most cases membrane antigens although in tumours they often appear in the cytoplasm perhaps because of accumulation in membrane vesicles (Hilkens et al., 1984) . Some antigens are, however, clearly expressed in the cytoplasm of normal cells and show heterogeneous staining of tumours. These include a prostate antigen described by Papsidero et al. (1983) and certain cytokeratin antigens (Gatter & Mason, 1982; Ramaekers et al., 1983) as discussed in more detail below.
The appearance of heterogeneous staining varies (Hand et al., 1983; Wilkinson et al., 1984; Wright et al., 1983) . As illustrated in Figures 1 and 2 (Hand et al., 1983; Wilkinson et al., 1984; Rasmussen et al., 1982) . One antibody will stain one population of tumour cells while another antibody, to a different antigen, may stain another population (Foster et al., 1982a; Rasmussen et al., 1982) .
This last observation confirms that heterogeneity in antigen expression is not just a "patchy staining" artefact caused, for example, by uneven fixation. In fact, the phenomenon can be demonstrated on viable, unfixed tissue by two-colour immunofluorescence, one antibody staining cells left unstained by the other and vice versa . Nor is heterogenous staining a peculiarity of monoclonal antibodies -it was first seen with polyclonal antisera such as rabbit antiserum to the epithelial membrane antigen described by Ormerod and co-workers (Greaves et al., 1981) . There must be some surface molecules present on all the cells of an epithelium that ought to be homogeneouslyexpressed, epithelium-specific antigens -certain transport proteins perhaps. Nevertheless, the great majority of monoclonal antibodies available at present only bind to some of the cells.
Antigenic heterogeneity is a property of normal epithelia "Antigenic heterogeneity" is not just a property of tumours but of a wide range of normal epithelia. Many monoclonal antibodies to epithelial tumours also stain the normal tissue well, and in general the normal epithelium stains just as heterogeneously as the tumours: a given antibody only stains some of the normal cells and different antibodies stain different populations of the cells. For example, in breast, antibody HMFGI stains about 30% of normal epithelial cells (Arklie et al., 1981) and in colon some antibodies stain cells predominantly in the crypts while others stain cells higher in the crypts and on the luminal face (Daar & Fabre, 1983; Finaq et al., 1982) . This is perhaps best shown by two-colour immunofluorescenceexamples of different populations of epithelial cells stained by different antibodies in normal epithelia of breast, endometrium and colon are shown in Figures 3-6 (Edwards & Brooks, 1984) .
Antigenic heterogeneity is constantly regenerated in clones, even of normal cells Antigenic heterogeneity is also shown by cells in culture, both in short term cultures of normal cells and in long-established tumour cell lines (Chang & Taylor-Papadimitriou, 1983; Hand et al., 1983; Peterson et al., 1983; Edwards & Brooks, 1984 Clones have been grown in monolayer culture to see whether they are homogeneous in antigen expression, from both normal breast epithelial cells and breast tumour cell lines. Single cells grow into clones displaying typical antigenic heterogeneity (Stoker et al., 1982; Peterson et al., 1983) . Figure 6 shows a typical, not extreme, example, from our own work (Edwards et al., 1984a (Hand et al., 1983; Peterson et al., 1983 (1982) found that antigen expression was very heterogeneous throughout the cell cycle, and increase in cell surface probably accounted for the modest increase in antigen expression between G1 and G2 phases. We obtained similar results using monoclonal antibodies to three distinct epithelial antigens (Huang et al., 1983) . Other antibodies to lung bind to carbohydrates (Iwaki et al., 1982; Lloyd et al., 1983) . At least three monoclonal antibodies raised to gastrointestinal carcinomas bind to distinct carbohydrate structures (Abe et al., 1983; Brockhaus et al., 1981; Magnani et al., 1983) . A number of the antibodies to epithelial cells bind to a (class of) high molecular-weight glycoprotein(s) that have been named epithelial membrane antigen (Ormerod et al., 1983) or PASO (Shimizu & Yamauchi, 1982) and at least some of them react with carbohydrate-containing parts of this molecule(s) (Burchell et al., 1983; Hilkens et al., 1984; Ormerod et al., 1984a, b; Ellis et al., 1984) .
Other antibodies to breast raised using milk-fat globule membrane as immunogen bind to other carbohydrate structures Gooi et al., 1983; Hilkens et al., 1984 (Gatter & Mason, 1982; Evans, 1983; Ramaekers et al., 1983) . Tumour cells may express the histocompatibility antigens HLA-A,-B,-C and DR heterogeneously (see below), and presumably the antibodies used to detect these antigens bind to protein portions of the molecules. Finally, it is also possible that all the cells have the antigen on their surface but that the structure recognised by a given antibody may only be accessible on certain cells. There is evidence that accessibility can determine the observed expression of antigens (Willison et al., 1982 (Klein, 1979) .
A priori, we might have expected that HLA-A, -B,-C and /32-microglobulin would be on all cells. In fact they are expressed, apparently uniformly, by normal breast and colon epithelium, but are absent, or present heterogeneously, in about half of malignant breast tumours (Fleming et al., 1981; Natali et al., 1983) . They were expressed normally in fourteen of fifteen colonic carcinomas but one showed only patchy expression (Daar & Fabre, 1983 (Daar & Fabre, 1983) . Heterogeneous expression seemed to correlate with relatively good differentiation (Rognum et al., 1983) . Normal colon epithelium is usually negative when stained for HLA-DR, but positive areas of apparently normal histology were found associated with tumour, and colon epithelium can express HLA-DR in graft versus host disease, and so can skin (Mason et al., 1981; Lampert et al., 1981 (Newman et al., 1980; Natali et al., 1983) . Carcinomas of the breast apparently usually express less HLA-DR than the normal, and do so heterogeneously (Natali et al., 1983 (Shevinsky et al., 1982) and a family of antigens that distinguishes cell types and stages of development in the nervous system has been shown B to be made up of the same polypeptide(s) with different glycosylation (Rougon et al., 1982) . The regular patterns of expression of antigen in some epithelia suggest that the cells expressing different antigens may be in different states of differentiation, or in in different stages of maturity. In particular, the steady change of antigen expression between the bottom and top of the crypts of the colon corresponds to the maturation of the cells (Figures 3-5 ; Finan et al., 1982; Daar & Fabre, 1983; Edwards & Brooks, 1984) . If surface antigen expression does correlate with the state of the cell we have some very interesting new insights into the differentiation and organisation of normal epithelia.
In some cases, it seems almost obvious that antigen expression in tumours correlates with differentiation. We are accustomed to leukaemias expressing surface antigens characteristic of a normal cell in a particular state of differentiation, and a similar scheme has been drawn up for melanomas (Houghton et al., 1983) . In squamous epithelia the expression of particular keratins is characteristic of stages in the life history of a cell. Keratin expression can be heterogeneous between cells in squamous carcinomas (Evans, 1983) , and it seems very likely that it reflects the state of differentiation of the tumour cells.
On the other hand, the heterogeneity of antigen expression in permanent cell lines and in small clones, and the absence of obvious correlation with morphology, perhaps suggests that the heterogeneity is merely a randomisation of surface structures, unrelated to other properties of the cell. It is possible to imagine functions for this. For example, it could protect against pathogen attack: a given pathogen would perhaps only be able to attack cells bearing particular carbohydrate groups. Alternatively, varying the glycosylation of cells might be a way of regulating the organisation of the epithelium through cell-cell interactions (Edwards. 1978) .
Implications
Possible implications for tumour cell heterogeneity in general It follows that at least some of the heterogeneity in surface antigen expression by the cells of a tumour arises from a normal property of epithelia and is rapidly regenerated in the progeny of a cell. This conflicts with some conventional views about tumour cell heterogeneity. It is well known that the cells of a tumour are often heterogeneous in various ways -in morphology, response to drugs, and so on (reviewed in Heppner, 1984; Owens et al., 1982; Woodruff, 1983) but the dramatic variability in the expression of antigens between cells has only been fully realised with the staining of sections of tumours with monoclonal antibodies. Heterogeneity has often been assumed, explicitly or implicitly, to be due to irreversible genetic changes (e.g. Nowell, 1976; Kerbel, 1979; Fidler & Hart, 1982; Nicolson, 1982) because they clearly do occur-for example karyotypically and morphologically variant strains can be isolated (Heppner, 1979; Owens et al., 1982) . Nowell (1976) Heterogeneity of cells has often been studied by isolating clones from a tumour (e.g. Heppner, 1979; Fidler & Hart, 1982; Owens et al., 1982) . The regeneration of heterogeneity in clones shows that this approach is inadequate to capture the full heterogeneity of a tumour (quite apart from the problem of drift in the properties of cloned lines in the long term (Neri & Nicolson, 1981) ). Many studies of tumour heterogeneity have been concerned with metastasis -few cells from a tumour form metastases, and attempts have been made to see whether there are sub-populations of tumour cells that metastasize more efficiently (Fidler & Hart, 1982) . Heterogeneity of the cell surface is particularly important in this context as it is likely to affect the ability of cells both to invade and to seed in metastatic sites. Clones have been grown from tumours to see if they have varied metastatic potential, usually measured as the ability to seed and form colonies in particular organs. Overall the results have been equivocal, and have never been dramatic: clones do not differ by orders of magnitude in their abilities to seed and form colonies (Fidler & Hart, 1982; Nicolson, 1982; Poste, 1982; Weiss et al., 1983 (Capone et al., 1984) .
Cell-surface heterogeneity may be a less serious problem in diagnosis. If 50% or even 20% of cells react with an antibody they will usually be detected in a section or smear. For example, Dearnaley et al. (1981) have shown that tumour cells can be detected in marrow biopsies from breast cancer patients, at a much lower level than can be detected by morphology alone, by staining with antibody, even though the antibodies used do not stain all the tumour cells.
Heterogeneity of antigen expression does, however, makes it difficult to score the staining of a tumour with a particular monoclonal antibodysee for example Figure 3 -so that it may be difficult to extract any clear-cut prognostic significance from the expression of a particular antigen by a tumour. Usually, a tumour cannot simply be scored as positive or negative for expression of an antigen, nor can most tumours be scored for the way an antigen is expressed, i.e. cytoplasmically, on the luminal membrane, on the membrane all around the cells, and so on, because different areas or cells of a given tumour will give a different score. However, we may come to recognise the significant features - Wilkinson et al. (1984) have developed a scoring system to try and analyse staining by taking these problems into account. They obtained both encouraging and discouraging results. By staining with antibody HMFG1 they claim to be able to classify 20% of patients into groups with either strikingly good or strikingly bad prognosis, respectively those with high staining of extracellular material or no staining of the tumour at all. However, 80% of patients showed other patterns of staining which could not be related to prognosis, and staining with antibody HMFG2, which generally stains tumours more than normal tissue, could not be related to prognosis at all. Others are attempting to classify tumours according to which of several antigens they express (Hand et al., 1983; Rasmussen et al., 1982) 
